Loading company
Latest annual · FY2025
Millions- Total revenues
- 598
- Operating income
- (64)
- Net income
- (53)
- Free cash flow
- (23)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 163
- Operating income
- (5)
- Net income
- (8)
- Free cash flow
- (4)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- -14.2%
- Revenue, 5 yearsFY2020 to FY2025
- +4.2%
- Net income, 5 yearsFY2020 to FY2025
- n/m
PAMT CORP (PAMT) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $598.1 million | $714.6 million | -16.3% | 10-K 2026-03-12 · proof |
| Operating income | -$64.1 million | -$36.8 million | 10-K 2026-03-12 · proof | |
| Net income | -$52.6 million | -$31.8 million | 10-K 2026-03-12 · proof | |
| Cash from operating activities | $17.3 million | $59 million | -70.6% | 10-K 2026-03-12 · proof |
| Free cash flow | -$23.4 million | -$81.7 million | 10-K 2026-03-12 · proof | |
| Total assets | $697.9 million | $741.7 million | -5.9% | 10-K 2026-03-12 · proof |
| Total liabilities | $487.4 million | $464.1 million | +5% | 10-K 2026-03-12 · proof |
| Cash and cash equivalents | $35.2 million | $68.1 million | -48.2% | 10-K 2026-03-12 · proof |
| Total debt | $333.9 million | $325.6 million | +2.5% | 10-K 2026-03-12 · proof |
- What was PAMT CORP (PAMT)'s revenue in fiscal 2025?
- PAMT CORP (PAMT) reported revenue of $598.1 million for fiscal 2025 (the year ended Dec 31, 2025), against $714.6 million the year before (-16.3%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What was PAMT CORP (PAMT)'s operating income in fiscal 2025?
- PAMT CORP (PAMT) reported operating income of -$64.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$36.8 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What was PAMT CORP (PAMT)'s net income in fiscal 2025?
- PAMT CORP (PAMT) reported net income of -$52.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$31.8 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What was PAMT CORP (PAMT)'s cash from operating activities in fiscal 2025?
- PAMT CORP (PAMT) reported cash from operating activities of $17.3 million for fiscal 2025 (the year ended Dec 31, 2025), against $59 million the year before (-70.6%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What was PAMT CORP (PAMT)'s free cash flow in fiscal 2025?
- PAMT CORP (PAMT) reported free cash flow of -$23.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$81.7 million the year before. Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What are PAMT CORP (PAMT)'s total assets?
- As of Dec 31, 2025, PAMT CORP (PAMT) reported total assets of $697.9 million, against $741.7 million a year earlier (-5.9%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What are PAMT CORP (PAMT)'s total liabilities?
- As of Dec 31, 2025, PAMT CORP (PAMT) reported total liabilities of $487.4 million, against $464.1 million a year earlier (+5%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What are PAMT CORP (PAMT)'s cash and cash equivalents?
- As of Dec 31, 2025, PAMT CORP (PAMT) reported cash and cash equivalents of $35.2 million, against $68.1 million a year earlier (-48.2%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
- What is PAMT CORP (PAMT)'s total debt?
- As of Dec 31, 2025, PAMT CORP (PAMT) reported total debt of $333.9 million, against $325.6 million a year earlier (+2.5%). Source: the 10-K filed with the SEC on Mar 12, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PAMT&period_type=annual&limit=5"Information only, not investment advice.